1 citations
,
December 2023 Hair grows in cycles and changes with age, starting from fetal development.
1 citations
,
August 2023 in “arXiv (Cornell University)” Deep learning effectively diagnoses scalp disorders, but improvements are needed.
1 citations
,
October 2022 in “Дерматовенерология Косметология” EGFR inhibitors for lung cancer can cause severe skin issues.
1 citations
,
October 2021 in “Journal of The American Academy of Dermatology” The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.
1 citations
,
April 2021 in “Clinical, Cosmetic and Investigational Dermatology” Conflicting findings in androgenic alopecia are likely due to biopsy location, hair diameter diversity, and hair follicle miniaturization.
1 citations
,
March 2021 in “Frontiers in Medicine” Female pattern hair loss shows similar characteristics in both genders and should be classified by hair loss patterns, not gender.
1 citations
,
September 2017 C-scores can help predict gain-of-function and loss-of-function mutations.
1 citations
,
September 2015 in “Pathology - Research and Practice” Stress during pregnancy can thin fetal skin.
1 citations
,
August 2012 in “Journal of acupuncture and meridian studies” Traditional Korean medicine combined with modern technology may improve hair removal treatments.
1 citations
,
November 2007 in “Humana Press eBooks” Most cases of high male hormone levels in women are due to polycystic ovary syndrome.
June 2026 in “Mendeley Data” The "Hair Loss Therapeutics Drug Database" is a comprehensive resource detailing pharmacological agents for treating hair loss disorders such as androgenetic alopecia, alopecia areata, and pseudofolliculitis barbae. It includes information on each drug's chemical properties, pharmacological classification, mechanism of action, molecular target, pharmacokinetics, clinical efficacy, dosage regimens, safety profile, regulatory status, and therapeutic uses. The database is designed to aid food and drug companies in research, drug development, bioinformatics, QSAR modeling, clinical decision support, and education.
June 2026 in “Mendeley Data” The "Hair Loss Therapeutics Drug Database" is a comprehensive resource detailing pharmacological agents for treating hair loss disorders such as androgenetic alopecia, alopecia areata, and pseudofolliculitis barbae. It includes information on each drug's chemical properties, pharmacological classification, mechanism of action, molecular target, pharmacokinetics, clinical efficacy, dosage regimens, safety profile, regulatory status, and therapeutic uses. The database is designed to aid food and drug companies in research, drug development, bioinformatics, QSAR modeling, clinical decision support, and education.
May 2026 in “International Journal of Technology in Education and Science” The AI system accurately classifies hair loss types and explains its decisions.
March 2026 in “Frontiers in Medicine” New therapies for rare skin diseases show promise but need more research.
March 2026 in “Skin Appendage Disorders” Children's hair care needs gentle products and better regulations due to unique hair and scalp differences.
January 2026 in “American Journal of Translational Research” The metoprolol-spironolactone combination improves heart function in patients with coronary heart disease and heart failure.
December 2025 in “IP Indian Journal of Clinical and Experimental Dermatology” Hair shaft disorders often indicate genetic or systemic issues and are managed by minimizing damage.
December 2025 in “Journal of Drug Discovery and Therapeutics” Spanlastics improve drug delivery by enhancing bioavailability and targeting, reducing side effects.
December 2025 in “Clinical Case Reports” The exosome injections were from stem cells and plants, not umbilical cords.
November 2025 in “Scientific Reports” AI improves accuracy and consistency in diagnosing male pattern hair loss.
A 16-year-old girl with lupus symptoms improved with treatment despite negative ANA tests.
October 2025 in “Journal of Cosmetic Dermatology” AOPT-MTL effectively and safely treats nasal blackheads in Asians.
September 2025 in “Frontiers in Immunology” Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.
AI can improve alopecia areata diagnosis with high accuracy.
August 2025 in “International Journal of Research Publication and Reviews” Quasi-drugs in Japan and South Korea are regulated to ensure safety and effectiveness, offering products with mild therapeutic effects.
July 2025 in “Lasers in Surgery and Medicine” Non-ablative fractional laser treatment safely improves hair growth and scalp appearance.
July 2025 in “International Journal of Trichology” Telogen effluvium is a common hair loss condition requiring careful diagnosis and treatment.
May 2025 in “Preprints.org” Unique microRNA patterns can help diagnose and treat severe alopecia areata.
February 2025 in “Tạp chí Y học Việt Nam” Posterior column injuries are common in tibial plateau fractures, and CT imaging is crucial for accurate treatment planning.
January 2025 in “International Journal of Trichology” Pattern hair loss is the most common type of alopecia.